The trajectory of opioid deaths in the United States is trending in the wrong direction, President Barack Obama said Tuesday.
By Kevin Freking, Associated Press
Forty-six people die every day in the U.S. after overdosing on prescription painkillers, causing some states to crack down. Are tighter laws creating new problems? Judy Woodruff gets views from Bob Twillman of the American Academy of Pain Management and…
By PBS NewsHour
Maine employers and consumers say that importing prescriptions from foreign mail-order pharmacies saves them a lot of money, so legislators passed a law legalizing imports. The drug industry and the state's pharmacists say imports can be dangerous, while supporters say…
Gwen Ifill talks to NPR reporter Julie Rovner about how changes to Medicare, including new taxes and adjustments in prescription drug coverage, under health care reform may impact Americans over the age of 65.
Depending on which, if any, health care reform plan passes through Congress, Medicare faces cuts as high as $500 billion. But what would cuts entail? Gwen Ifill reports.
A doctor assesses a new FDA panel recommendation for a ban on such popular painkillers as Vicodin, Percocet and other drugs containing acetaminophen.
The Supreme Court heard arguments in a case about whether Arizona school officials were justified in strip-searching a 13 year-old girl for prescription drugs on another student's tip. The National Law Journal's Marcia Coyle explains the case and its implications…
A coalition of college and university presidents recently urged lawmakers to discuss making age 18 the legal limit for drinking as a means to curb alcohol abuse among students. Two university officials take up the controversial initiative that has sparked…
Pharmaceutical company Merck knew in 2001 that its arthritis drug Vioxx could harm patients and used staffers to "ghostwrite" favorable research on the drug, articles in the Journal of the American Medical Association report. Susan Dentzer examines the charges.
Support Provided By: Learn more
Educate your inbox
Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else.